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Activation of M1 muscarinic acetylcholine receptors (M1
mAChR) inhibits M-type potassium currents (IK(M) ) and N-type
calcium currents (ICa) in mammalian sympathetic ganglia. Pre-
vious antisense experiments suggested that, in rat superior
cervical ganglion (SCG) neurons, both effects were partly me-
diated by the G-protein Gaq (Delmas et al., 1998a; Haley et al.,
1998a), but did not eliminate a contribution by other pertussis
toxin (PTX)-insensitive G-proteins. We have tested this further
using mice deficient in the Gaq gene.
PTX-insensitive M1 mAChR inhibition of ICa was strongly
reduced in Gaq 2/2 mouse SCG neurons and was fully re-
stored by acute overexpression of Gaq. In contrast, M1 mAChR
inhibition of IK(M) persisted in Gaq2/2 mouse SCG cells. How-
ever, unlike rat SCG neurons, muscarinic inhibition of IK(M) was
partly PTX-sensitive. Residual (PTX-insensitive) IK(M) inhibition
was slightly reduced in Gaq 2/2 neurons, and the remaining
response was then suppressed by anti-Gaq/11 antibodies.
Bradykinin (BK) also inhibits IK(M) in rat SCG neurons via a
PTX-insensitive G-protein (Gq and/or G11; Jones et al., 1995).
In mouse SCG neurons, IK(M) inhibition by BK was fully PTX-
resistant. It was unchanged in Gaq 2/2 mice but was abolished
by anti-Gaq/11 antibody.
We conclude that, in mouse SCG neurons (1) M1 mAChR
inhibition of ICa is mediated principally by Gq, (2) M1 mAChR
inhibition of IK(M) is mediated partly by Gq, more substantially
by G11, and partly by a PTX-sensitive G-protein(s), and (3)
BK-induced inhibition of IK(M) is mediated wholly by G11.
Key words: M current; calcium current; G-protein; superior
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The excitability of neurons is controlled by the convergent action
of many different ion channels, including voltage-gated K1 and
Ca21 channels and ligand gated ion channels. N-Type Ca21
channels have complex effects on cell excitability. They permit
Ca21 influx at presynaptic terminals, triggering exocytosis,
thereby contributing to excitability. However, they also act to limit
cell excitability by providing the Ca21 necessary to open Ca21-
activated K1 channels, resulting in a prolonged afterhyperpolar-
ization and action potential accommodation (Davies et al., 1996;
Sah, 1996). The M-type potassium current (IK(M)) also acts to
dampen cell excitability; it increases upon depolarization, hyper-
polarizing the cell and keeping it clamped around rest and thus
limiting action potential firing (Brown, 1988; Wang and McKin-
non, 1995). Both the N-type Ca21 channel and IK(M) can be
inhibited by G-protein-coupled receptors, such as the muscarinic
acetylcholine M1 receptor (M1 mAChR) (Marrion et al., 1989;
Bernheim et al., 1992), and coincident inhibition of both currents
results in large increases in cell excitability and action potential
discharge (Jones and Adams, 1987; Brown, 1988, 1999).
In rat superior cervical ganglion (SCG), inhibition of ICa and
IK(M) by agonists acting at the M1 mAChR appears to use very
similar transduction mechanisms, and it has been suggested that
they may share a common pathway (Hille, 1994). The first step in
this pathway is the activation of a G-protein that is insensitive to
pertussis toxin (PTX) (Brown et al., 1989; Bernheim et al., 1992).
Previous experiments using the injection of antibodies directed
against the common C terminus of Gaq and Ga11 (Caulfield et al.,
1994) and the expression of separate antisense constructs specific
to Gaq or Ga11 (Delmas et al., 1998a; Haley et al., 1998a)
suggested that the G-protein primarily involved is Gaq. However,
because suppression by either method was incomplete, the par-
ticipation of other G-protein(s) could not be discounted.
Bradykinin (BK) also inhibits IK(M) in rat SCG neurons
through stimulation of B2 BK receptors (Jones et al., 1995). This
effect was strongly attenuated by anti-Gaq/11 antibodies (Jones et
al., 1995), but the specific G-protein involved has not been further
identified. It may, in fact, differ from that required for mAChR-
induced inhibition because BK-induced inhibition clearly involves
the activation of phospholipase C, whereas M1 mAChR-induced
inhibition appears not to (Cruzblanca et al., 1998; Haley et al.,
1998b).
In an attempt to further define the role of Gaq in transducing
the effects of M1 mAChR and B2 BK receptors, we have therefore
investigated the inhibition of ICa and IK(M) by agonists for these
receptors in SCG neurons isolated from mice lacking Gaq (Of-
fermanns et al., 1997a,b).
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Parts of this work have been published previously in abstract
form (Haley et al., 1998c).
MATERIALS AND METHODS
Gaq-Deficient mice. Mice deficient in the Gaq gene (Gaq 2/2) were
generated by targeted disruption with a neomycin gene as described
previously (Offermanns et al., 1997a). Gaq-Deficient mice used in the
experiments were obtained by mating either Gaq knock-out males with
heterozygous females or heterozygous males and females (to obtain
wild-type and knock-out littermates). Mice were kept on a C57BL 3
129/Sv background, and genotypes were confirmed by PCR on genomic
DNA from tail snips of each mouse.
Cell culture. Sympathetic neurons were isolated from Gaq knock-out
and wild-type mice that were at least 5 weeks old. Wild-type mice were
either C57BL/6J (Harlan, Bicester, UK) or from litters also containing
Gaq knock-out littermates; results obtained were the same from both
these groups and so have been pooled. We also used ICR mouse (coding
for outbred albino mouse; Harlan) to compare properties of SCG neu-
rons derived from different strain of mouse. SCG were removed, and
neurons were cultured using standard procedures as described previously
for rat (Delmas et al., 1998b).
Microinjection. In a few experiments, GaoA1B or Gaq/11 antiserum
(OC2 and CQ1 respectively, from G. Milligan) (Caulfield et al., 1994,
Delmas et al., 1998a, 1999) or an expression plasmid encoding Gaq were
pressure-injected into the cytoplasm (antisera) or nucleus (plasmid) of
SCG neurons 2 d in culture using a microinjector (Eppendorf, Hamburg,
Germany). To allow identification of the injected neurons for recording,
FITC-dextran (70,000 MW; Molecular Probes, Leiden, The Nether-
lands) was added in a final concentration of 0.2% (antisera) (Jones et al.,
1995) or 0.5% (plasmid) (Haley et al., 1998a). Cells injected with the
antisera were recorded at least 2 hr after injection, whereas those
injected with the Gaq-encoding plasmid were recorded 24 hr later.
Electrophysiology. Currents were measured from SCG neurons cul-
tured for 2–3 d, using the amphotericin-B perforated patch technique
(Horn and Marty, 1988; Rae et al., 1991). Patch electrodes (2–5 MV)
were filled by dipping the tip for 40 sec into the appropriate filtered
internal solution, and the pipette was then back-filled with the internal
solution containing 0.07–0.1 mg/ml amphotericin-B. High-resistance
seals (.2 GV) were initially achieved and, after amphotericin-B perme-
abilization, access resistances were generally ,25 MV for IK(M) record-
ings and ,15 MV for ICa recordings. SCG neurons were perfused (5–10
ml/min) with an external solution consisting of (in mM): NaCl 120, KCl
3, HEPES 5, NaHCO3 23, glucose 11, MgCl2 1.2, CaCl2 2.5, and
tetrodotoxin 0.0005, pH 7.4, maintained at 32°C.
IK(M) recording. The internal solution comprised of (in mM): potassium
acetate 80, KCl 30, HEPES 40, and MgCl2 3, adjusted to pH 7.3–7.4 with
KOH (280 mOsm/l with K acetate). Cells were voltage-clamped using an
Axoclamp-2A (switching frequencies 3–5 kHz, filter 0.1 kHz) from Axon
Instruments (Foster City, CA). IK(M) was measured as a slowly develop-
ing inward deactivation relaxation after a 1 sec jump to a command
potential of approximately 245 mV from a holding potential of approx-
imately 225 mV (Haley et al., 1998a). Inhibition was measured as the
fractional reduction in the amplitude of the IK(M) deactivation relaxation
in response to either cumulatively increasing concentrations of ox-
otremorine methiodide (Oxo-M) (Research Biochemicals, Natick, MA)
or a single application of 1 nM BK (Bachem, Torrance, CA).
ICa recording. Perforated patch recordings were conducted primarily as
described previously (Delmas et al., 1999). Pipettes had a resistance of
2–3 MV when filled with the following solution (in mM): CsCl 30,
caesium acetate 110, HEPES 10, and MgCl2 1, pH 7.2–7.3 with CsOH
(300 mOsm/l). Cells were voltage-clamped using an Axopatch 200A
amplifier (Axon Instruments). Series resistance and membrane capaci-
tance were partially compensated (.80%). Current traces were low-pass
filtered at 2–5 kHz using a four-pole Bessel filter. Leak and capacitance
currents were subtracted digitally using the P/6 subtraction procedure of
pClamp6 (Axon Instruments). ICa was elicited from a holding potential
of 270 mV with a three-voltage pulse protocol consisting of a test pulse
to 0 mV applied before and after a conditioning depolarizing step to
190 mV.
For experiments with Bordetella PTX (Speywood, Maidenhead, Berk-
shire, UK), SCG neurons were incubated with 1 mg/ml PTX in the
culture medium for at least 24 hr before recording. Data are expressed as
mean 6 SEM, and statistical analysis of dose–response curves used
two-way ANOVA to compare treatments across all concentrations. If a
significant effect of treatment was found overall, further analysis was
performed using the two-way ANOVA to determine which treatment
groups contributed to this significance. The bradykinin data were ana-
lyzed with one-way ANOVA, and if an overall effect of treatment was
found, this was followed by Students–Newman–Keuls multiple compar-
ison test. Analysis of ICa and IK(M) current densities and neuron mem-
brane potential was analyzed using Student’s t test. p , 0.05 was consid-
ered significant.
Immunocytochemistry. Successful injection of Gao or Gaq/11 antiserum
was confirmed by staining. After recording, cells were fixed in acetone,
washed, incubated with biotinylated Fab2 swine anti-rabbit antibody (the
antiserum was raised in rabbit), and then incubated with avidin–biotin
complex. The alkaline phosphatase substrate 5-bromo-4-chloro-3-indoxyl
phosphate/nitro blue tetrazolium chloride (BCIP/NBT) (Dako, Carpin-
teria, CA) was applied for 5 min, and the reaction was quenched with
water. Neurons containing the injected antiserum were clearly distin-
guished as containing the dark purple BCIP/NBT product. Detection of
expressed Gaq after injection of the Gaq plasmid was confirmed using
the above protocol and preceding it with a 1 hr incubation with a 1:2000
dilution of a Gaq antibody (IQB2) (Milligan et al., 1993).
RESULTS
M1 mAChR-induced inhibition of ICa and IK(M) in mouse
versus rat SCG
The mAChR agonist Oxo-M inhibited both ICa and IK(M) (see
also Hamilton et al., 1997) in SCG from mouse. However, the
dose–response curves were shifted to the right in mouse com-
pared with rat neurons (Fig. 1). IC50 values for IK(M) inhibition
were 0.4 and 0.7 mM in rat and wild-type mouse, respectively. For
M1 mAChR inhibition of ICa, IC50 were 800 nM and 1.1 mM in rat
and mouse, respectively.
M1 mAChR inhibition of ICa is reduced in Gaq 2/2
mouse SCG neurons
In rat SCG, inhibition of ICa by mAChR agonists results from the
activation of two separate pathways: a voltage- and PTX-sensitive
M4 mAChR pathway (M2 receptors in mice) (Shapiro et al., 1999)
that requires GaoA and a voltage- and PTX-insensitive M1
mAChR pathway that mostly involves Gaq (Delmas et al., 1998a).
In mice, total mAChR inhibition of ICa was significantly ( p ,
0.002) reduced when Gaq was deleted. Thus, 1 and 10 mM Oxo-M
Figure 1. Dose–response curves (mean 6 SEM plus best-fit curve) for
Oxo-M inhibition of ICa and IK(M) in rat and mouse SCG. ICa , Left,
Oxo-M dose–response curves determined after treatment with PTX,
thereby isolating the M1 mAChR-mediated component. n values for each
concentration point range from 3 to 7. IK(M) , Right, Oxo-M dose–response
curve in wild-type mouse SCG (n 5 9) is significantly different from that
seen in rat SCG (n 5 4; p , 0.001). The rat IK(M) dose–response curve
data are taken from Haley et al. (1998a), and the rat ICa dose–response
curve data are from Delmas et al. (1998a). Legend applies to both panels.
All cells were recorded using the perforated patch method.
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resulted in 49 6 4% (n 5 8) and 68 6 4% (n 5 12) inhibition,
respectively, in wild-type (Gaq 1/1) mouse neurons and 29 6
3% (n 5 5) and 57 6 3% (n 5 5) inhibition in Gaq 2/2 neurons.
Inhibition in Gaq 2/2 neurons was more voltage-dependent than
in wild-type neurons, with facilitation ratio of 1.4 6 0.2 (n 5 10)
and 0.94 6 0.1 (n 5 8), respectively (data not shown). Inhibition
by 10 mM noradrenaline (NA) (which requires both GaoA and Gai
in rat) (Caulfield et al., 1994; Delmas et al., 1999) was not altered
when Gaq was absent (wild type, 66 6 3%, n 5 8; Gaq 2/2, 62 6
5%, n 5 5).
Incubation with 1 mM PTX inactivates members of the Gao/i
G-protein family, removes the PTX-sensitive mAChR inhibition,
and isolates the M1 mAChR inhibition, as well as abolishes
inhibition by NA (Schofield, 1991; Zhu and Ikeda, 1994). Inhibi-
tion by NA was, as expected, abolished in PTX-treated cells from
both wild-type and Gaq 2/2 mice. After PTX treatment, it
became clear that the reduction in M1 plus M2 inhibition ob-
served in the Gaq 2/2 cells resulted from an almost complete
loss of the voltage-insensitive M1 mAChR-mediated inhibition
(Fig. 2). To be sure that the loss of M1 mAChR inhibition of ICa
was attributable to the absence of Gaq, we acutely overexpressed
Gaq in cultured SCG neurons from Gaq 2/2 mice. Twenty-four
hours after injection of a plasmid encoding for Gaq, M1 mAChR
inhibition was fully restored (Fig. 2C). This reinstated inhibition
was specific because NA inhibition was not rescued by Gaq
overexpression in PTX-treated cells (Fig. 2). These findings ac-
cord with previous data from this laboratory that M1 mAChR
inhibition of ICa in rat SCG is primarily mediated by Gaq (Del-
mas et al., 1998a). It should be noted that the ICa density (nor-
malized to cell capacitance) was significantly lower in Gaq 2/2
neurons (27 6 2 pA/pF, n 5 10) compared with wild-type mouse
SCG (38 6 2 pA/pF, n 5 12, p , 0.01). There was no difference
between ICa density in wild-type mouse and rat SCG (rat, 42 6 2
pA/pF, n 5 19).
M1 mAChR inhibition of IK(M) is not reduced in SCG
from Gaq 2/2 mouse
In rat SCG, inhibition of IK(M) by mAChR agonists is mediated,
at least in part, by Gaq (Haley et al., 1998a), so one would predict
a loss of inhibition in neurons lacking Gaq. We were surprised,
therefore, to discover that inhibition of IK(M) by Oxo-M was not
reduced in Gaq 2/2 SCG compared with wild-type neurons (Fig.
3). Indeed, Oxo-M produced significantly more inhibition in Gaq
2/2 neurons ( p , 0.05), and the dose–response curve lay to the
left of the wild-type dose–response (Fig. 3B). IK(M) density (nor-
malized to cell capacitance) was not changed in Gaq 2/2 mouse
SCG compared with wild type, and neither was the resting mem-
brane potential (wild type, 2.5 6 0.5 pA/pF, n 5 8; 258.0 6 1.3
mV, n 5 9; Gaq 2/2, 3.3 6 1.1 pA/pF, n 5 9; 256.3 6 1.3 mV,
n 5 11), and these did not differ from rat SCG (2.4 6 0.3 pA/pF,
n 5 10; 259.9 6 1.3 mV).
M1 mAChR inhibition of IK(M) partly involves PTX-
sensitive G-proteins in mouse SCG
One factor contributing to the persistence of mAChR-induced
inhibition of IK(M) in neurons from Gaq-deficient mice became
apparent when we tested the effect of PTX. In contrast to previ-
ous observations on rat SCG neurons (Brown et al., 1989; Bern-
heim et al., 1992; Haley et al., 1998a), PTX treatment significantly
reduced inhibition by Oxo-M in neurons from both wild-type
Figure 2. M1 mAChR inhibition of ICa
is markedly reduced in Gaq 2/2 mice.
All experiments were performed on
neurons pretreated with PTX. A, ICa
waveforms in SCG neurons from wild-
type (lef t) and Gaq 2/2 mice (right) in
the absence and presence of 10 mM
Oxo-M, using the three-step voltage pro-
tocol illustrated above each waveform.
The conditioning step to 190 mV did
not reverse Oxo-M inhibition in either
wild-type or Gaq 2/2 neurons, con-
firming the voltage-independent nature
of the PTX-insensitive inhibition. Cali-
bration: 5 msec. B, Gaq is expressed in a
Gaq 2/2 neuron after injection of a
Gaq expression plasmid (injected cell
indicated by arrow). C, In Gaq 2/2 neu-
rons, Oxo-M inhibition of ICa is restored
by exogenous expression of Gaq. D,
Summary of M1 mAChR and noradren-
ergic inhibitions of ICa. Note that NA
inhibition cannot be restored in Gaq
2/2 SCG neurons by expression of Gaq.
n ranges from 6 to 10 for Oxo-M data
and from 4 to 7 for NA data.
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mice ( p , 0.01) and Gaq 2/2 mice ( p , 0.0001) (Fig. 4). In fact,
the effect of PTX was greater in Gaq-deficient neurons, and the
dose-response curve for the PTX-insensitive component of inhi-
bition showed a significant ( p , 0.02) rightward shift in Gaq 2/2
neurons. Thus, at 0.3 mM Oxo-M, the mean inhibition of IK(M) was
reduced from 15 6 3 to 6 6 4%. Hence, it appeared that Gaq
contributed a component of PTX-insensitive inhibition at low
agonist concentrations but that, at high agonist concentrations,
activation of another PTX-insensitive G-protein predominated.
One possibility is that this residual PTX-insensitive inhibition
might have been mediated by G11, because expression of consti-
tutively activated Ga11 is also capable of inhibiting IK(M) in rat
SCG neurons (Haley et al., 1998a). To test this, we injected
antibodies directed against the C terminus of Gaq/11 into the cell
cytosol of PTX-treated neurons, using antibodies against Gao as
a control (Caulfield et al., 1994). Anti-Gaq/11 strongly reduced
PTX-insensitive inhibition in neurons from wild-type mice and
virtually annulled the residual inhibition in neurons from Gaq
2/2 mice ( p , 0.0001). Thus, the residual PTX-insensitive
inhibition in neurons from Gaq 2/2 mice results from activation
of Ga11 because the antibody is specific to Gaq and Ga11, and
Gaq is absent.
Inhibition of IK(M) by BK is mediated by Ga11 in
Gaq 2/2 neurons
For these experiments, a single application of a low concentration
(1 nM) of BK was made to each neuron tested because slow
recovery from inhibition precluded repeated applications to the
same neuron and desensitization precluded applications of incre-
mental concentrations (Jones et al., 1995; Cruzblanca et al.,
1998). At 1 nM, BK inhibited IK(M) in wild-type mouse SCG
neurons by 25 6 4% (n 5 8). This was not significantly different
from that in rat SCG neurons (29 6 7%; n 5 8; data not shown).
Unlike mAChR-induced inhibition, the effect of BK on mouse
neurons was not reduced by PTX (Fig. 5). This accords with
previous observations on rat neurons (Jones et al., 1995). No
inhibition of ICa by 1 nM BK could be detected.
No significant reduction of BK-induced inhibition of IK(M) was
observed in Gaq 2/2 neurons. However, injection of an antibody
against Gaq/11 substantially ( p , 0.05 vs anti-Go antibody) re-
duced IK(M) inhibition in wild-type mouse neurons (as in rat
neurons; Jones et al., 1995) and abolished inhibition in neurons
from Gaq 2/2 mice ( p , 0.01) (Fig. 5B).
DISCUSSION
Using mice lacking Gaq, we have demonstrated that M1 mAChR
inhibition of ICa requires Gaq because regulation was essentially
lost in Gaq 2/2 neurons (Fig. 2). This was not a result of
secondary effects on transduction mechanisms arising from an
absence of Gaq during development because inhibition could be
fully restored by acute overexpression of Gaq in Gaq 2/2 neu-
rons (Fig. 2); thus, the remaining components of the inhibitory
pathway were still present and functional in these mutant cells. In
contrast, neither the inhibition produced by NA nor the PTX-
sensitive (M2) component of mAChR inhibition (Shapiro et al.,
1999) were reduced after deletion of the Gaq genes. Hence, these
results in mouse neurons are in complete accord with previous
conclusions from observations on rat SCG neurons using
G-protein antibody injections and antisense depletion (Caulfield
et al., 1994; Delmas et al., 1998a) that Gaq is the primary
G-protein involved in M1 mAChR-induced inhibition of ICa but
is not involved in the inhibition produced by activating M2/4
mAChRs or a2 adrenergic receptors. It is especially worth noting
(particularly in connection with our observations on IK(M); see
below) that Ga11 appears not to be able to substitute for Gaq in
Gaq 2/2 mice, although it is able to interact with M1 mAChRs
(Offermanns et al., 1994; Gudermann et al., 1996) and although
expression of a constitutively active form of Ga11 can inhibit ICa
just like Gaq (unpublished observations; Delmas et al., 1998a).
In contrast [and surprisingly, in view of previous observations
in rat SCG neurons using Gaq antisense (Haley et al., 1998a)],
mAChR-induced inhibition of IK(M) was not reduced in neurons
from Gaq 2/2 mice. One contributory reason for this seemed to
be that IK(M) inhibition after mAChR stimulation was partly
sensitive to PTX. When this component was eliminated, it ap-
peared that some part of the inhibition (particularly at low agonist
concentrations) was mediated by Gaq because the dose–response
curve for Oxo-M-induced M current inhibition was shifted signif-
icantly to the right in Gaq 2/2 mice. Nevertheless, it was clear
Figure 3. M1 mAChR inhibition of IK(M) is not reduced in Gaq 2/2
mice. A, IK(M) deactivation relaxation elicited by a 220 mV step for 1 sec
from a holding potential of 225 mV. Waveforms (average of 6 traces) are
from SCG neurons of wild-type (top) and Gaq 2/2 (bottom) mice and are
shown in the absence and presence of increasing concentrations of Oxo-M
(micromolar). Dotted lines indicate 0 pA. Calibration: 250 pA. B, Mean 6
SEM data (plus best-fit curves) for Oxo-M inhibition of IK(M) in wild-type
and Gaq 2/2 SCG neurons. Oxo-M dose–response curve in Gaq 2/2
neurons (n 5 8) was significantly different from wild type (n 5 9; p ,
0.05). IC50 and Hill slope values for inhibition in Gaq 2/2 cells are 0.6 mM
and 1.1, respectively. C, Oxo-M dose–response curves in wild-type and
Gaq 2/2 SCG neurons treated with PTX. IC50 and Hill slope values were
1.3 mM and 0.93, and 1.7 mM and 1.16 in wild-type and Gaq 2/2 cells,
respectively.
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that a considerable proportion of the inhibition must have been
mediated by another PTX-insensitive G-protein. In Gaq-deficient
neurons, this G-protein was identifiable as Ga11, because the
residual PTX-insensitive inhibition was virtually annulled using
an antibody directed against the unique but common C terminus
to Gaq and Ga11. Thus, in the Gaq-deficient mice, we conclude
that mAChR-induced M current inhibition is maintained by Ga11
and by an increased contribution of the (unidentified) PTX-
sensitive pathway.
Thus, the present experiments reveal two clear differences
from the inferences drawn from previous work on mAChR-
induced M current inhibition in rat SCG neurons: the additional
involvement of a PTX-sensitive G-protein and the greater poten-
tial involvement of Ga11. One possible explanation for the appar-
ent involvement of a PTX-sensitive G-protein is that, in mouse
ganglion cells, stimulation of M4 or M2 receptors might also
inhibit IK(M). However, this seems unlikely, because Hamilton et
al. (1997) found that mAChR-induced M current inhibition was
Figure 5. Ga11 mediates BK inhibition of IK(M)
in Gaq 2/2 neurons. A, Representative wave-
forms (1 sec step from 225 to 245 mV) recorded
from Gaq 2/2 neurons treated with PTX and
injected with GaoA1B (lef t) or Gaq/11 (right) an-
tibody. BK (1 nM) inhibited IK(M) in GaoA1B-
injected neurons but not when the Gaq/11 anti-
body was injected. The dotted lines represent 0
pA. Calibration: 250 pA. B, Mean 6 SEM data
for inhibition by 1 nM BK in wild-type and Gaq
2/2 neurons. Neither PTX treatment nor injec-
tion of the GaoA1B antibody significantly altered
inhibition by BK in either wild-type or Gaq 2/2
neurons. Injection of the Gaq/11 antibody re-
duced BK inhibition in both wild-type and Gaq
2/2 cells ( p , 0.01 for both compared with
PTX plus GaoA1B antibody).
Figure 4. PTX-sensitive G-proteins
and Ga11 mediate Oxo-M inhibition of
IK(M) in Gaq 2/2 neurons. A, Represen-
tative waveforms (1 sec step from 225 to
245 mV) recorded from Gaq 2/2 neu-
rons treated with PTX and injected with
either GaoA1B antibody or Gaq/11 anti-
body. Whereas cumulative concentra-
tions of Oxo-M (micromolar) still pro-
duce inhibition in the GaoA1B antibody-
injected cell, there was very little
inhibition in presence of the Gaq/11 an-
tibody. Dotted lines indicate 0 pA. Cali-
bration: 250 pA. B, Mean 6 SEM data
(plus best-fit curves) for Oxo-M inhibi-
tion of IK(M) in wild-type and Gaq 2/2
neurons. PTX treatment significantly
reduced Oxo-M inhibition in both wild-
type (n 5 8; p , 0.01) and Gaq 2/2
neurons (n 5 10; p , 0.0001). Injection
of a GaoA1B antibody had no effect on
PTX-treated cells from either wild-type
(n 5 7) or Gaq 2/2 (n 5 7) mice and
served as an injection control. Injection
of a Gaq/11 antibody reduced the re-
maining PTX-insensitive inhibition in
both the wild-type (n 5 4; p , 0.0001
compared with GaoA1B antibody-
injected cells) and Gaq 2/2 (n 5 5; p ,
0.0001 compared with GaoA1B antibody-
injected cells) neurons. Legend applies to
both panels. Insets demonstrate the presence of the injected antibodies in SCG neurons (injected cells indicated by arrow): lef t, GaoA1B antibody in
wild-type neuron; right, Gaq/11 antibody in Gaq 2/2 neuron.
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completely annulled in mice deficient in the M1 receptor gene,
implying that, as in rat neurons (Marrion et al., 1989; Bernheim
et al., 1992), muscarinic inhibition of IK(M) was mediated entirely
by M1 mAChRs. Although M1 receptors are usually considered to
couple exclusively to PTX-insensitive G-proteins, there have
been occasional reports of at least partial PTX-sensitive re-
sponses after expression of cloned M1 receptors (Stein et al.,
1988; Ashkenazy et al., 1989). Because this PTX-sensitive path-
way seems unique to mouse neurons and may have limited general
significance, we have not so far made any serious attempt to
identify the species of G-protein involved.
Regarding the involvement of Ga11, in previous experiments
on rat neurons, anti-Gaq antisense produced a rightward shift of
the dose–response curve for inhibition of IK(M) by Oxo-M (Haley
et al., 1998a), not dissimilar to that seen in Gaq 2/2 mouse
neurons. However, although this might also suggest the involve-
ment of another PTX-insensitive G-protein, antisense to Ga11
had no effect on the inhibitory effect of Oxo-M in rat neurons.
Hence, it was concluded that the limited effect of Gaq antisense
probably resulted from incomplete protein suppression rather
than to the additional effect of another G-protein. Nevertheless, it
is necessary to point out that, although Ga11 can sustain mAChR-
induced M current inhibition in Gaq-deficient mice, we have no
direct evidence from the present experiments that Ga11 mediates
any part of the response of normal (wild-type) mouse neurons to
Oxo-M; the reduced inhibition seen in the presence of the Gaq/11
antibody could equally well have been attributable to antagonism
of either endogenous Gaq or Ga11. The large contribution of
Ga11 in Gaq 2/2 neurons might then be an adaptive change,
perhaps resulting from a redistribution of G-proteins in the
plasma membrane, because there is no evidence for compensa-
tory overexpression of Ga11 in the nervous system of these mice
(Offermanns et al., 1997b). Hence, the present observations do
not necessarily negate our previous conclusion that mAChR-
induced M current inhibition in normal rat neurons results pri-
marily from activation of Gaq. In this context, it should be noted
that previous observations have revealed differences between the
coupling of muscarinic receptors to ion channels in mouse and rat
SCG neurons. Thus, in the mouse, inhibition of ICa is mediated by
M2 receptors (Shapiro et al., 1999) whereas the corresponding
response in rat SCG neurons is mediated by M4 receptors (Bern-
heim et al., 1992); indeed, although rat neurons possess func-
tional M2 receptors capable of activating PTX-sensitive
G-proteins, they appear not to inhibit ICa (Fernandez-Fernandez
et al., 1999).
The effects of BK on IK(M) in mouse ganglion cells seem to
match those on rat SCG neurons much more closely. Thus, 1 nM
BK produced the same amount of inhibition in both, and neither
showed any sensitivity to PTX (unlike muscarinic inhibition).
Previous experiments on rat neurons using G-protein antibodies
(Jones et al., 1995) strongly suggested that inhibition was medi-
ated by either Gaq or Ga11 (or both) but could not identify which.
Because in the present experiments inhibition was unchanged in
neurons from Gaq 2/2 mice and then annulled by anti-Gaq/11
antibody, we infer that inhibition in normal SCG neurons is
probably mediated exclusively by Ga11 (although with the caveat
regarding possible adaptive responses after Gaq deletion ex-
pressed above). Lack of any involvement of Gaq would accord
with the fact that, unlike mAChR stimulation, BK did not inhibit
ICa in the mouse ganglion cells.
The reason for this apparent selectivity of BK receptors for
Ga11 in mouse neurons (and possibly in rat neurons) is unclear.
Although it is usually assumed that BK can activate Gaq, we are
unaware of any experiments that unequivocally distinguish effects
mediated by Gaq from those that might equally be mediated by
Ga11. On the contrary, Ricupero et al. (1997) have reported that
BK-induced stimulation of phospholipase C was enhanced, rather
than inhibited, in mouse embryonic stem cells lacking Gaq,
whereas Wilk-Blaszczak et al. (1994b) identified G13 as the
G-protein responsible for the PTX-insensitive component of ICa
inhibition in neuroblastoma hybrid cells. [In previous experi-
ments, these authors (Wilk-Blaszczak et al., 1994a) had identified
Gq/11 as mediating the phospholipase C-driven activation of
IK(Ca) in these cells but, because this was from anti-Gq/11 antibody
infusion, it could have resulted from activation of Gq,G11, or
both.]
In conclusion, the present results point to a surprising degree of
divergence at the G-protein level in the coupling of M1 mAChR
and B2 BK receptors to Ca
21 and KM
1 channels in SCG neurons
(Fig. 6). Thus, in the mouse ganglion, M1 mAChR inhibition of
ICa appears to be mediated exclusively (or almost so) by Gaq,
whereas inhibition of IK(M) also involves both Ga11 and an addi-
tional unidentified PTX-sensitive G-protein. BK does not inhibit
ICa, and its inhibition of IK(M) is probably mediated exclusively by
Ga11. This divergence at the level of G-protein coupling may go
some way toward explaining the apparent divergence in the
subsequent steps to M current inhibition after activation of M1
mAChRs or B2 BK receptors, namely, that BK-induced inhibition
appears to involve activation of a phospholipase C, whereas M1
muscarinic inhibition does not (Cruzblanca et al., 1998; Haley et
Figure 6. Diagram to summarize projected G-protein involvement for
M1 mAChR- and B2 BK receptor-induced inhibition of ICa and IK(M)
channels in rat SCG neurons and in wild-type and Gaq-deficient mouse
SCG neurons.
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al., 1998b). The difference in G-protein coupling from M1
mAChRs to Ca21 channels and KM
1 channels might equally
imply that, contrary to previous inferences (Hille, 1994), the
modulation of these two channels may also involve different
transduction pathways.
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